176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.43%
Positive revenue growth while MRVL is negative. John Neff might see a notable competitive edge here.
14.79%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
19.89%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
19.89%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
33.41%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
31.43%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.50%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
7.80%
Dividend growth above 1.5x MRVL's 0.85%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
17.37%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-13.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
121.65%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
169.14%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
109.03%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
392.59%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
208.14%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
175.44%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
298.40%
Below 50% of MRVL's 4409.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
557.65%
5Y net income/share CAGR above 1.5x MRVL's 3.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
419.83%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
161.35%
10Y equity/share CAGR above 1.5x MRVL's 45.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
58.37%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
51.85%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
98.71%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
76.81%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
8.40%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-7.12%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.35%
Asset growth above 1.5x MRVL's 0.56%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
17.03%
BV/share growth above 1.5x MRVL's 2.07%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.50%
We’re deleveraging while MRVL stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
9.96%
R&D growth drastically higher vs. MRVL's 8.78%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.77%
SG&A declining or stable vs. MRVL's 15.53%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.